Reveal Pharmaceuticals
PrivateLast Round
Grant
Jun 5, 2023
Total Funding Raised
$7.99M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Reveal Pharmaceuticals operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was a Grant round in June 2023.
Reveal Pharmaceuticals is a biotechnology company that develops gadolinium-free MRI contrast agents to provide safer medical imaging and diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Imaging
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Reveal Pharmaceuticals Comparables
Compare Reveal Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoxort | 86% | |
| GE HealthCare Technologies Inc. | 80% | |
| Phos4nova B.V. | 78% |
For institutional investors. Book with your work email.
Reveal Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jun 5, 2023 | ||||
| Grant | Jun 9, 2022 | ||||
| Grant | Sep 3, 2019 | ||||
| Grant | Oct 1, 2018 | ||||
| Grant | Sep 3, 2018 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Reveal Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| NIH RADx | Grant |
| MassVentures | Grant |
| Massachusetts Life Sciences Center | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 36% MoM.
- Jul 24, 2026
Monthly visitors increased 38% MoM.
For institutional investors. Book with your work email.
Reveal Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Reveal Pharmaceuticals's valuation, stock price, and market status.
Is Reveal Pharmaceuticals a public or private company?
Reveal Pharmaceuticals is a private company.
What is the current stock price of Reveal Pharmaceuticals?
Reveal Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Reveal Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Reveal Pharmaceuticals worth (valuation)?
Valuation information for Reveal Pharmaceuticals is not publicly available.
Can I buy Reveal Pharmaceuticals stock?
Reveal Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Reveal Pharmaceuticals's last funding round?
Reveal Pharmaceuticals's most recent funding round was Grant on June 5, 2023.
Who are the main investors in Reveal Pharmaceuticals?
Key investors in Reveal Pharmaceuticals include National Cancer Institute, NIH RADx, MassVentures, Massachusetts Life Sciences Center.
Will Reveal Pharmaceuticals IPO soon?
No public IPO plans have been announced for Reveal Pharmaceuticals.
How can I track Reveal Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Reveal Pharmaceuticals's shares on secondary markets.